**Question:** Drug of choice for Zollinger-Ellison syndrome

**Core Concept:** Zollinger-Ellison syndrome (ZES) is a rare disorder characterized by the overproduction of gastric acid, leading to peptic ulcers and gastroesophageal reflux disease. The primary treatment for ZES involves inhibiting gastric acid secretion.

**Why the Correct Answer is Right:** The correct answer is **D.** Omeprazole, a proton pump inhibitor (PPI), is the drug of choice for Zollinger-Ellison syndrome due to its strong ability to inhibit gastric acid secretion. PPIs work by blocking the H+/K+-ATPase enzyme found on the gastric parietal cells, preventing the formation of hydrogen ions and thus reducing acid production.

**Why Each Wrong Option is Incorrect:**

A. Omeprazole is not the drug of choice for ZES, but it is an effective treatment option.
B. While PPIs are effective in reducing gastric acid secretion, they are not specifically tailored for Zollinger-Ellison syndrome and may not address the underlying tumor mass.
C. Omeprazole is not the only option for treating ZES, as other drugs like H2-receptor antagonists like ranitidine can also be used, but omeprazole is generally preferred due to its stronger inhibition of acid production.
D. Omeprazole is not the most suitable option for ZES patients, as interfering with tumor growth should be a primary goal in Zollinger-Ellison syndrome treatment.

**Clinical Pearl:** In Zollinger-Ellison syndrome, addressing the underlying tumor growth is crucial, but omeprazole is an effective drug for controlling gastric acid secretion and managing the symptoms associated with excessive acid production. In severe cases, a combination therapy with somatostatin analogs (e.g., octreotide) might be used to target both the tumor growth and gastric acid secretion simultaneously.